Tenapanor FDA approval date

The FDA approved Tenapanor (IBSRELA) on 12 Sep 2019.

FDA approval date
12 Sep 2019

Drug identity checked against registry records

Also recorded as IBSRELA; Ibsrela; RDX5791, AZD1722

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-09-12DayTenapanorFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211801", "applicant_as_listed_by_fda": "ARDELYX INC", "brand_names": ["IBSRELA"], "active_ingredients": ["TENAPANOR HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190912", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026